Xuemei Zhou
-
- NF-κB Signaling Pathways 2
-
- Ubiquitin and proteasome pathways 3
- Fibroblast Growth Factor Research 2
- Pluripotent Stem Cells Research 1
-
- Natural Antidiabetic Agents Studies 2
-
- Immune cells in cancer 2
- interferon and immune responses 1
-
- Virus-based gene therapy research 1
In The Last Decade
Xuemei Zhou
15 papers receiving 359 citations
Peers
Comparison fields: 5 of 79
- Biochemistry 32
- Cancer Research 44
- Molecular Biology 191
- Endocrinology, Diabetes and Metabolism 44
- Immunology 51
Countries citing papers authored by Xuemei Zhou
This map shows the geographic impact of Xuemei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Zhou more than expected).
Fields of papers citing papers by Xuemei Zhou
This network shows the impact of papers produced by Xuemei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Zhou. The network helps show where Xuemei Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuemei Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 47 | |
| 3 | 2022 | 10 | |
| 4 | 2021 | 80 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 20 | |
| 9 | 2020 | 16 | |
| 10 | 2018 | 28 | |
| 11 | 2015 | 12 | |
| 12 | 2014 | 82 | |
| 13 | 2011 | 10 | |
| 14 | Study of brain-derived neurotrophic factor gene transgenic neural stem cells in the rat retina. | 2009 | 5 |
| 15 | 2009 | 11 |
About Xuemei Zhou
Xuemei Zhou is a scholar working on Cancer Research, Developmental Neuroscience and Biophysics, having authored 15 papers that have together received 363 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Fibroblast Growth Factor Research (2 papers), Immune cells in cancer (2 papers), Natural Antidiabetic Agents Studies (2 papers), NF-κB Signaling Pathways (2 papers), interferon and immune responses (1 paper), Virus-based gene therapy research (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Biochemistry (32 citations), Cancer Research (44 citations) and Molecular Biology (191 citations). Xuemei Zhou has collaborated with scholars based in China, Czechia and Rwanda. Frequent co-authors include Ling Xiao, Xi Liu, Bochu Wang, Jun Tan, Liancai Zhu, Xian Yang, Chun‐Ping Cui, Yesheng Fu, Cui Hua Liu and Lingqiang Zhang. Their work appears in journals such as Molecular Cell, PLoS ONE and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.